Category: Endoscopic / Arthroscopic
Medical device manufacturers making endoscopic / arthroscopic products.
Smith & Nephew Inc.'s patent infringement lawsuit against Interlace Medical Inc. accuses Interlace Medical Inc. CTO Ronald Adams of bringing the technology with him when he left the British medical products conglomerate in 2006.
Smith & Nephew Inc. (NYSE:SNN) hit Interlace Medical Inc. with a lawsuit accusing the Framingham, Mass.-based firm of infringing a patent with its MyoSure hysteroscopy device.
Smith & Nephew, which has operations in Andover, Mass., accused Interlace chief technology officer Ronald Adams, an SNN employee from 2002 to 2006, of bringing the technology with him when he jumped ship for then-startup Interlace. The patent covers an arthroscopic surgical instrument designed to cut semi-rigid tissue.
First-quarter sales rise 10 percent for Solos Endoscopy Inc., but Q1 losses widen by more than 68 percent.
Solos Endoscopy Inc. (OTC:SNDY) posted a 10 percent sales increase for the first quarter, but saw its Q1 losses widen by 68.4 percent.
The Boston-based endoscopic instruments and imaging equipment maker posted sales of $105,000 for the three months ended March 31, compared with $95,000 during the same period last year.
But net losses widened to $297,000, up from $177,000 during Q1 2009.
Syncro Medical Innovations raises $800,000 in a pair of debt offerings to increase market penetration of its Syncro Bluetube feeding tube.
By Mary Vanac
Syncro Medical Innovations raised an additional $500,000 in a debt offering it plans to use to more aggressively push an improved version of its innovative feeding tube to market.
Solos Endoscopy Inc. taps Fred Schiemann to be its new CFO and board member.
Solos Endoscopy Inc. (OTC:SNDY) tapped Fred Schiemann to be its new CFO and board member.
Schiemann was CFO of Xtreme Oil & Gas Inc. and "several" other corporations, according to a press release, and is treasurer of Biz2Biz.com.
SurgiQuest Inc. and Vascular Insights LLP may commence sale of two new surgical devices.
A pair of Connecticut medical device firms won regulatory nods in the U.S. and Europe.
SurgiQuest Inc. won 510(k) clearance from the Food & Drug Administration for its new line of 5mm AnchorPort laparoscopy trocars and Vascular Insights LLP landed CE Mark approval in Europe for its ClariVein Occlusion Catheter.
SurgiQuest touts its device's ability to adjust for differences in each patient, calling it "the world's first elastomeric single incision laparoscopy kit."
A federal judge in Texas upholds a $4.8 million decision against Applied Medical Resources Corp. in a patent infringement lawsuit filed by Covidien plc over laparoscopic trocars.
A federal judge in Texas upheld a $4.8 million verdict from Texas jury in a patent infringement lawsuit filed by Covidien plc (NYSE:COV) against Applied Medical Resources Corp. but denied Covidien's bid for a permanent injunction against future sales of the infringing products.
Stem cell firm Stemgent Inc. and surgical tool maker Cambridge Endoscopic Devices Inc. each raise millions in equity offerings.
Cambridge Endoscopic Devices Inc. and Stemgent Inc. each made quick gains from multi-million dollar equity offerings that opened April 30.
Cambridge Endo, an endoscopic surgical tool maker based in Framingham, Mass., sold to one individual $3 million of a $7.5 million offering, according to Securities & Exchange Commission filings. CEO Woojin Lee and directors Walter Winshall and Phil Henderson were listed as principals in the deal.